An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period
Clinical trial NCT00299676 · COMPLETED
Trial details
- NCT number
- NCT00299676
- Sponsor
- Janssen-Cilag Pty Ltd
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2005-05-01
- Primary completion
- 2008-03-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.